Remove Aortic valve Remove Cardiovascular Interventions Remove Strokes
article thumbnail

Outcomes Following Transcatheter Aortic Valve Replacement for Aortic Stenosis in Patients With Type 0 Bicuspid, Type 1 Bicuspid, and Tricuspid Aortic Valves

Circulation: Cardiovascular Interventions

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Data concerning the outcomes of transcatheter aortic valve replacement in type 0 bicuspid aortic stenosis (AS) are scarce. Self-expanding transcatheter heart valves were used in the majority of patients (n=1160; 91.4%).

article thumbnail

Association Between Polyvascular Disease and Transcatheter Aortic Valve Replacement Outcomes: Insights from the STS/ACC TVT Registry

Circulation: Cardiovascular Interventions

Circulation: Cardiovascular Interventions, Ahead of Print. Background:Atherosclerotic cardiovascular disease (ASCVD) is highly prevalent in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Primary outcome was all-cause mortality. 2VB-PVD, HR 1.12; 95% CI, 1.09-1.15,

article thumbnail

Supplementing Randomized Trial Data to Answer a Real World Question: Discharge to Home Status as a Heuristic for Stroke Severity After Transcatheter Aortic Valve Replacement

Circulation: Cardiovascular Interventions

Circulation: Cardiovascular Interventions, Ahead of Print.

article thumbnail

Lifelong risk of stroke after TAVR: Findings from SwissTAVI Registry

Cardiology Update

Stroke stands as a major contributor to global morbidity and mortality, imposing a substantial burden on patients, societies, and healthcare systems worldwide. Within the realm of transcatheter aortic valve replacement (TAVR), stroke emerges as a recognized adverse event, manifesting at various stages during and after the procedure.

TAVR 111
article thumbnail

Efficacy of the Glucagon-Like Peptide-1 Agonist Exenatide in Patients Undergoing CABG or Aortic Valve Replacement: A Randomized Double-Blind Clinical Trial

Circulation: Cardiovascular Interventions

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:GLP-1 (glucagon-like peptide-1) agonists have been proven beneficial in reducing the risk of and injury associated with several cardiovascular diseases. The intervention was an infusion of 17.4 Patients were predominantly low risk.

article thumbnail

Transcarotid Versus Surgical Aortic Valve Replacement for the Treatment of Severe Aortic Stenosis

Circulation: Cardiovascular Interventions

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Current guidelines recommend surgical aortic valve replacement (SAVR) for patients with severe aortic stenosis and unfavorable iliofemoral access. versus TC-TAVR, 12.7%; hazard ratio, 1.63 [95% CI, 0.982.73]).CONCLUSIONS:TC-TAVR

article thumbnail

Use of Claims to Assess Outcomes and Treatment Effects in the Evolut Low Risk Trial

Circulation: Cardiovascular Interventions

Circulation: Cardiovascular Interventions, Volume 18, Issue 1 , Page e014592, January 1, 2025. BACKGROUND:Food and Drug Administrationmandated postmarket studies for transcatheter aortic valve replacement in low-risk populations plan to use passively collected registry data linked to claims for long-term follow-up out to 10 years.